Triptorelin

Triptorelin
Clinical data
Trade names Trelstar
AHFS/Drugs.com Micromedex Detailed Consumer Information
Pregnancy
category
  • X
ATC code L02AE04 (WHO) QH01CA97 (WHO)
Legal status
Legal status
  • ℞ (Prescription only)
Pharmacokinetic data
Excretion Kidney
Identifiers
CAS Number 57773-63-4 N
PubChem (CID) 25074470
IUPHAR/BPS 1177
DrugBank DB06825 N
ChemSpider 17290424 N
UNII 9081Y98W2V YesY
KEGG D06247 N
ChEBI CHEBI:63633 N
ChEMBL CHEMBL1201334 N
ECHA InfoCard 100.165.044
Chemical and physical data
Formula C64H82N18O13
Molar mass 1311.5 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Triptorelin, a decapeptide (pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2), is a gonadotropin-releasing hormone agonist (GnRH agonist) used as the acetate or pamoate salts. By causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH).

Medical uses

Triptorelin is used to treat prostate cancer.[1]

Names

Triptorelin is marketed under the brand names Decapeptyl (Ipsen) and Diphereline and Gonapeptyl (Ferring Pharmaceuticals). In the United States, it is sold by Watson Pharmaceuticals as Trelstar. In Iran Triptorelin is marketed under the brand name Variopeptyl.

References

  1. "triptorelin (Intramuscular route)". drugs.com. Retrieved 11 November 2016.


This article is issued from Wikipedia - version of the 11/12/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.